Millennium Management
TERN

Millennium Management’s Terns Pharmaceuticals TERN Stock Holding History

Millennium Management’s Portfolio TERN Stock Details TERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$159M Buy
3,011,558
+2,024,252
+205% +$83.1M 0.07% 279
2025
Q4 		$39.9M Buy
987,306
+45,722
+5% +$1.06M 0.02% 964
2025
Q3 		$7.07M Sell
941,584
-55,242
-6% -$353K ﹤0.01% 2751
2025
Q2 		$3.72M Sell
996,826
-120,616
-11% -$377K ﹤0.01% 3284
2025
Q1 		$3.08M Sell
1,117,442
-492,773
-31% -$2.01M ﹤0.01% 3359
2024
Q4 		$8.92M Buy
1,610,215
+31,681
+2% +$215K ﹤0.01% 2293
2024
Q3 		$13.2M Buy
1,578,534
+438,142
+38% +$3.6M 0.01% 1946
2024
Q2 		$7.77M Sell
1,140,392
-2,292,400
-67% -$13.9M ﹤0.01% 2315
2024
Q1 		$22.5M Buy
3,432,792
+1,444,151
+73% +$9.43M 0.01% 1463
2023
Q4 		$12.9M Buy
1,988,641
+374,080
+23% +$1.98M 0.01% 1943
2023
Q3 		$8.12M Sell
1,614,561
-667,681
-29% -$4.24M ﹤0.01% 2246
2023
Q2 		$20M Buy
2,282,242
+1,199,859
+111% +$14M 0.01% 1388
2023
Q1 		$12.8M Sell
1,082,383
-374,822
-26% -$3.58M 0.01% 1727
2022
Q4 		$14.8M Buy
1,457,205
+1,074,492
+281% +$7.15M 0.01% 1717
2022
Q3 		$2.25M Buy
382,713
+105,025
+38% +$390K ﹤0.01% 3631
2022
Q2 		$689K Buy
277,688
+189,178
+214% +$378K ﹤0.01% 4706
2022
Q1 		$263K Buy
88,510
+35,229
+66% +$150K ﹤0.01% 5661
2021
Q4 		$377K Buy
+53,281
New +$444K ﹤0.01% 5300
2021
Q3 		– Sell
-14,769
Closed -$181K – 7248
2021
Q2 		$181K Buy
+14,769
New +$252K ﹤0.01% 6058

Other funds holding TERN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Millennium Management's TERN Position: Q1 2026 in Review

Millennium Management increased its Terns Pharmaceuticals (TERN) stake by 205% in Q1 2026, buying an estimated $83.1M and bringing the position to 3,011,558 shares worth $159M. The position accounts for 0.07% of the portfolio, ranked #279.

Millennium Management first reported a position in TERN in Q2 2021 and has held it in 19 quarters since. 317 funds tracked by Wall St. Rank hold TERN as of Q1 2026.

  • Millennium Management held 3,011,558 shares of Terns Pharmaceuticals worth $159M as of Q1 2026.
  • Millennium Management bought 2,024,252 Terns Pharmaceuticals shares in Q1 2026, an estimated $83.1M.
  • Terns Pharmaceuticals made up 0.07% of Millennium Management's portfolio in Q1 2026, its #279 holding.
  • Millennium Management first reported a position in Terns Pharmaceuticals in Q2 2021 and has held it in 19 quarters since.
  • 317 funds tracked by Wall St. Rank held Terns Pharmaceuticals as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.